Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 25

1.

High-stage urachal adenocarcinoma can be associated with microsatellite instability and KRAS mutations.

Sirintrapun SJ, Ward M, Woo J, Cimic A.

Hum Pathol. 2014 Feb;45(2):327-30. doi: 10.1016/j.humpath.2013.09.008. Epub 2013 Oct 3.

PMID:
24355196
2.

BRAF provides proliferation and survival signals in MSI colorectal carcinoma cells displaying BRAF(V600E) but not KRAS mutations.

Preto A, Figueiredo J, Velho S, Ribeiro AS, Soares P, Oliveira C, Seruca R.

J Pathol. 2008 Feb;214(3):320-7.

PMID:
18098337
3.

KRAS mutation and microsatellite instability in endometrial adenocarcinomas showing MELF-type myometrial invasion.

Stewart CJ, Amanuel B, Grieu F, Carrello A, Iacopetta B.

J Clin Pathol. 2010 Jul;63(7):604-8. doi: 10.1136/jcp.2009.069500.

PMID:
20591910
4.

BRAF, KRAS and PIK3CA mutations in colorectal serrated polyps and cancer: primary or secondary genetic events in colorectal carcinogenesis?

Velho S, Moutinho C, Cirnes L, Albuquerque C, Hamelin R, Schmitt F, Carneiro F, Oliveira C, Seruca R.

BMC Cancer. 2008 Sep 9;8:255. doi: 10.1186/1471-2407-8-255.

5.

PIK3CA and PTEN gene and exon mutation-specific clinicopathologic and molecular associations in colorectal cancer.

Day FL, Jorissen RN, Lipton L, Mouradov D, Sakthianandeswaren A, Christie M, Li S, Tsui C, Tie J, Desai J, Xu ZZ, Molloy P, Whitehall V, Leggett BA, Jones IT, McLaughlin S, Ward RL, Hawkins NJ, Ruszkiewicz AR, Moore J, Busam D, Zhao Q, Strausberg RL, Gibbs P, Sieber OM.

Clin Cancer Res. 2013 Jun 15;19(12):3285-96. doi: 10.1158/1078-0432.CCR-12-3614. Epub 2013 Apr 30.

6.

EGFR, KRAS, BRAF-mutations and microsatellite instability are absent in goblet cell carcinoids of the appendix.

Dimmler A, Geddert H, Faller G.

Pathol Res Pract. 2014 May;210(5):274-8. doi: 10.1016/j.prp.2014.01.002. Epub 2014 Jan 31.

PMID:
24560515
7.

Does neoadjuvant therapy alter KRAS and/or MSI results in rectal adenocarcinoma testing?

Ondrejka SL, Schaeffer DF, Jakubowski MA, Owen DA, Bronner MP.

Am J Surg Pathol. 2011 Sep;35(9):1327-30. doi: 10.1097/PAS.0b013e3182253800.

PMID:
21836482
8.

Distinct clinicohistologic features of inflammatory bowel disease-associated colorectal adenocarcinoma: in comparison with sporadic microsatellite-stable and Lynch syndrome-related colorectal adenocarcinoma.

Liu X, Goldblum JR, Zhao Z, Landau M, Heald B, Pai R, Lin J.

Am J Surg Pathol. 2012 Aug;36(8):1228-33. doi: 10.1097/PAS.0b013e318253645a.

PMID:
22790862
9.

Similarity of the phenotypic patterns associated with BRAF and KRAS mutations in colorectal neoplasia.

Yuen ST, Davies H, Chan TL, Ho JW, Bignell GR, Cox C, Stephens P, Edkins S, Tsui WW, Chan AS, Futreal PA, Stratton MR, Wooster R, Leung SY.

Cancer Res. 2002 Nov 15;62(22):6451-5.

10.

Clinicopathologic characteristics, CpG island methylator phenotype, and BRAF mutations in microsatellite-stable colorectal cancers without chromosomal instability.

Kakar S, Deng G, Sahai V, Matsuzaki K, Tanaka H, Miura S, Kim YS.

Arch Pathol Lab Med. 2008 Jun;132(6):958-64. doi: 10.1043/1543-2165(2008)132[958:CCCIMP]2.0.CO;2.

PMID:
18517279
12.

Clinicopathologic features and utility of immunohistochemical markers in signet-ring cell adenocarcinoma of the bladder.

Thomas AA, Stephenson AJ, Campbell SC, Jones JS, Hansel DE.

Hum Pathol. 2009 Jan;40(1):108-16. doi: 10.1016/j.humpath.2008.06.022. Epub 2008 Sep 11.

PMID:
18789486
13.

Clinicopathologic and molecular profiles of microsatellite unstable Barrett Esophagus-associated adenocarcinoma.

Farris AB 3rd, Demicco EG, Le LP, Finberg KE, Miller J, Mandal R, Fukuoka J, Cohen C, Gaissert HA, Zukerberg LR, Lauwers GY, Iafrate AJ, Mino-Kenudson M.

Am J Surg Pathol. 2011 May;35(5):647-55. doi: 10.1097/PAS.0b013e31820f18a2.

PMID:
21422910
14.

Updates in the Pathologic Diagnosis and Classification of Epithelial Neoplasms of Urachal Origin.

Paner GP, Lopez-Beltran A, Sirohi D, Amin MB.

Adv Anat Pathol. 2016 Mar;23(2):71-83. doi: 10.1097/PAP.0000000000000110. Review.

PMID:
26849813
15.

Small bowel adenocarcinoma phenotyping, a clinicobiological prognostic study.

Aparicio T, Svrcek M, Zaanan A, Beohou E, Laforest A, Afchain P, Mitry E, Taieb J, Di Fiore F, Gornet JM, Thirot-Bidault A, Sobhani I, Malka D, Lecomte T, Locher C, Bonnetain F, Laurent-Puig P.

Br J Cancer. 2013 Dec 10;109(12):3057-66. doi: 10.1038/bjc.2013.677. Epub 2013 Nov 5.

16.

Signature of microsatellite instability, KRAS and BRAF gene mutations in German patients with locally advanced rectal adenocarcinoma before and after neoadjuvant 5-FU radiochemotherapy.

Demes M, Scheil-Bertram S, Bartsch H, Fisseler-Eckhoff A.

J Gastrointest Oncol. 2013 Jun;4(2):182-92. doi: 10.3978/j.issn.2078-6891.2013.012.

17.

Urachal carcinoma: a pathologic and clinical study of 46 cases.

Dhillon J, Liang Y, Kamat AM, Siefker-Radtke A, Dinney CP, Czerniak B, Guo CC.

Hum Pathol. 2015 Dec;46(12):1808-14. doi: 10.1016/j.humpath.2015.07.021. Epub 2015 Aug 12.

18.

Whole exome sequencing of urachal adenocarcinoma reveals recurrent NF1 mutations.

Singh H, Liu Y, Xiao X, Lin L, Kim J, Van Hummelen P, Wu CL, Bass AJ, Saylor PJ.

Oncotarget. 2016 May 17;7(20):29211-5. doi: 10.18632/oncotarget.8640.

19.

Frequency of genetic alterations observed in cell cycle regulatory proteins and microsatellite instability in gallbladder adenocarcinoma: a translational perspective.

Mishra PK, Raghuram GV, Jatawa SK, Bhargava A, Varshney S.

Asian Pac J Cancer Prev. 2011;12(2):573-4. No abstract available.

20.

The Increasing Relevance of Tumour Histology in Determining Oncological Outcomes in Colorectal Cancer.

Nagtegaal ID, Hugen N.

Curr Colorectal Cancer Rep. 2015;11(5):259-266. Review.

Supplemental Content

Support Center